Concepedia

Henri Sasmor

HS

30

Publications

3.5K

Citations

23

H-Index

1983

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of Colorado Boulder

University of Colorado Health

Novartis (Switzerland)

University of Colorado Anschutz Medical Campus

Henri Sasmor is an author at Ionis Pharmaceuticals (United States) specializing in molecular biology, natural sciences, and biochemistry.

Top concepts

Publications per year

1983–2003

30

Publications

30

2′-O-(2-Methoxy)ethyl-modified Anti-intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 mRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial Cells

Brenda F. Baker, Sidney S. Lot, Thomas P. Condon et al. · Journal of Biological Chemistry · 1997 · 374 citations · Full text

Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats

Richard S. Geary, Tanya Watanabe, L Truong et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 280 citations

Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.

Paul A. Cossum, Henri Sasmor, D Dellinger et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 266 citations

A perfectly symmetric lac operator binds the lac repressor very tightly.

John R. Sadler, Henri Sasmor, Joan L. Betz · Proceedings of the National Academy of Sciences · 1983 · 264 citations · Full text

, , +16

Pharmacokinetic properties of several novel oligonucleotide analogs in mice.

Stanley T. Crooke, Melissa Graham, J E Zuckerman et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 228 citations

Rows per page

1–5 of 30